• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Dec 24, 2019 at 12:32: AM
via Swiss biopharma Roche is betting more than $1 billion that Sarepta Therapeutics, which recently won FDA approval for its second RNA medicine for Duchenne muscular dystrophy, will get its lead gene therapy treatment across the finish line too.

article source
 




Top Bottom
Back
Quote